Chemed Corporation
General ticker "CHE" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $7.6B (TTM average)
Chemed Corporation does not follow the US Stock Market performance with the rate: -36.8%.
Estimated limits based on current volatility of 1.1%: low 448.41$, high 458.49$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-17, amount 0.60$ (Y0.53%)
- Total employees count: 15695 (+4.0%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Liquidity and credit risks, Market competition, Cybersecurity threats, Climate change and natural disasters, Regulatory and compliance
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [446.45$, 611.47$]
- 2025-12-31 to 2026-12-31 estimated range: [462.71$, 633.41$]
Financial Metrics affecting the CHE estimates:
- Negative: with PPE of 22.6 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 15.08
- Positive: Return on assets ratio (scaled to [-100,100]) of 15.33 > 6.04
- Positive: 0.04 < Operating cash flow per share per price, % of 5.32
- Positive: Shareholder equity ratio, % of 67.06 > 64.17
- Positive: Interest expense per share per price, % of 0.02 <= 0.74
- Positive: -9.48 < Industry operating profit margin (median), % of -2.81
- Negative: Industry operating cash flow per share per price (median), % of 3.20 <= 5.42
- Positive: Inventory ratio change, % of -0.19 <= 0
Short-term CHE quotes
Long-term CHE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,131.27MM | $2,262.16MM | $2,430.84MM |
| Operating Expenses | $1,787.78MM | $1,921.59MM | $2,064.35MM |
| Operating Income | $343.50MM | $340.57MM | $366.49MM |
| Non-Operating Income | $-13.82MM | $9.80MM | $32.97MM |
| Interest Expense | $4.58MM | $3.11MM | $1.78MM |
| Income(Loss) | $329.68MM | $350.37MM | $399.46MM |
| Taxes | $80.06MM | $77.86MM | $97.47MM |
| Profit(Loss)* | $249.62MM | $272.51MM | $302.00MM |
| Stockholders Equity | $798.72MM | $1,107.88MM | $1,118.99MM |
| Inventory | $10.27MM | $12.00MM | $8.19MM |
| Assets | $1,442.01MM | $1,668.10MM | $1,668.58MM |
| Operating Cash Flow | $309.89MM | $330.30MM | $417.50MM |
| Capital expenditure | $57.33MM | $56.85MM | $49.53MM |
| Investing Cash Flow | $-59.40MM | $-60.64MM | $-143.91MM |
| Financing Cash Flow | $-209.25MM | $-79.83MM | $-359.19MM |
| Earnings Per Share** | $16.72 | $18.11 | $20.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.